The government has intensified efforts to transform India into a global MedTech exporter. According to the latest update, exports of medical devices surged from US$ 2.9 billion to US$ 4.1 billion recently  a strong signal that Indian-made devices are gaining global competitiveness. 

This momentum is being driven by a combination of regulatory reforms, infrastructure investments, manufacturing incentives, and strategic policy support. Key measures include the PLI scheme for medical devices (with a ₹3,420 crore outlay), which covers high-end imaging, diagnostics, critical-care, and implantable devices that India previously imported. 

Complementing that is the recently launched MedTech scheme (₹500 crore), which backs component manufacturing, common facilities, clinical-study infrastructure, skill development and export promotion  laying the groundwork for a robust domestic manufacturing and export ecosystem.

To reduce import dependence, the government is also encouraging development of device-parks offering shared high-quality infrastructure. Several such parks e.g. in Greater Noida, Ujjain, Kanchipuram  are nearing completion. Land has been allotted to many manufacturers, and plant construction has started for a number of units.

As a result, India’s share of domestically produced medical devices has risen significantly over the past 5 years. Whereas earlier only about 10% of domestic demand was met locally, now roughly 30% is sourced from Indian manufacturers; for several high-end device categories, domestic share has reached ~20%. 

Industry analysts suggest that with continued momentum  supported by export-friendly regulation, investment in infrastructure, and rising global demand  Indian MedTech exports could scale dramatically in the coming years.